Drug recall · March 8, 2023
Gabapentin Tablets recall
Why: Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.
- Lots / codes
Lot # G177092, Exp. 11/24
- Quantity
- 4,392 bottles
- Company
- Sciegen Pharmaceuticals Inc, Hauppauge, NY
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- February 17, 2023 · Voluntary: Firm initiated
- Classified
- February 27, 2023
- Reported
- March 8, 2023
- Ended
- June 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gabapentin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.